OPTIVISC SINGLE
OPTIVISC SINGLE is a cross-linked, non-surgical, non-pharmacologic therapy for Knee Osteoarthritis, a disease of joints characterized by a progressive degradation of the cartilage and bone deformation. OPTIVISC is a treatment for patients who suffer from Osteoarthritis showing symptoms like knee pain, stiffness, articulator limited mobility, crack, swelling, functional impairment and even deformations.
OPTIVISC SINGLE is highly viscous gel formulated with high molecular weight (2.8 to 3.2 Mio Dalton) injectable grade hyaluronic acid from bio-fermentation origin, HA gel indicated for use as an intra-articular injection in the patients suffering from Osteoarthritis of knee joint.
How OPTIVISC Works?
OPTIVISC is the exogenous source of Hyaluronic Acid that restores the Synovial fluid balance in OA condition. The administration of OPTIVISC increases the viscosity of the Synovial fluid, restoring its lubricating, shock-absorbing and filtering properties. Furthermore, it re-establishes the protective HA coating over the inner surface of the joint and increases the scavenging of free radicals.
As a result, inflammation of the Synovium is reduced. This relieves pain and increases mobility of the joint.
Features
Single injection viscosupplement
Pain relief and improved mobility for up to 12 months
TECHNICAL SPECIFICATIONS
| HA CONTENT | 3% (90mg) |
| PH | Between 6.8 to 7.6 |
| MOLECULAR WEIGHT | 2.8 to 3.2 million dalton |
| PACK | 1 × 3 ml PFS |
IndIcatIons
For knee joint
SUPPLY
OPTIVISC Single is supplied sterile and non-pyrogenic in Latex-free pre-filled syringes with 3 ml fill volumes.
ADDITIONAL PRODUCT
OPTIVISC Single is available with 60 mg/2ml for special orders in this segment.
Categories
Company
Media
Follow Us
© Copyright Biotech /Terms Of Use - Privacy Policy
Version 2_CT_1212222